IL188442A0 - Compositions for affecting weight loss - Google Patents

Compositions for affecting weight loss

Info

Publication number
IL188442A0
IL188442A0 IL188442A IL18844207A IL188442A0 IL 188442 A0 IL188442 A0 IL 188442A0 IL 188442 A IL188442 A IL 188442A IL 18844207 A IL18844207 A IL 18844207A IL 188442 A0 IL188442 A0 IL 188442A0
Authority
IL
Israel
Prior art keywords
compositions
weight loss
affecting weight
affecting
loss
Prior art date
Application number
IL188442A
Other languages
English (en)
Original Assignee
Orexigen Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orexigen Therapeutics Inc filed Critical Orexigen Therapeutics Inc
Publication of IL188442A0 publication Critical patent/IL188442A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL188442A 2005-07-27 2007-12-26 Compositions for affecting weight loss IL188442A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70287705P 2005-07-27 2005-07-27
PCT/US2006/028875 WO2007016108A1 (en) 2005-07-27 2006-07-24 Compositions for affecting weight loss

Publications (1)

Publication Number Publication Date
IL188442A0 true IL188442A0 (en) 2008-04-13

Family

ID=37198787

Family Applications (1)

Application Number Title Priority Date Filing Date
IL188442A IL188442A0 (en) 2005-07-27 2007-12-26 Compositions for affecting weight loss

Country Status (12)

Country Link
US (1) US20070117827A1 (https=)
EP (1) EP1907005A1 (https=)
JP (1) JP2009502931A (https=)
KR (1) KR20080042092A (https=)
CN (1) CN101237886A (https=)
AU (1) AU2006275914A1 (https=)
BR (1) BRPI0613911A2 (https=)
CA (1) CA2614539A1 (https=)
IL (1) IL188442A0 (https=)
MX (1) MX2008001136A (https=)
RU (1) RU2007147609A (https=)
WO (1) WO2007016108A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215552A1 (en) * 2002-05-17 2005-09-29 Gadde Kishore M Method for treating obesity
EP1617832B1 (en) * 2003-04-29 2008-03-12 Orexigen Therapeutics, Inc. Compositions for affecting weight loss
CN101370488B (zh) 2005-11-22 2012-07-18 奥雷西根治疗公司 增加胰岛素敏感性的组合物
WO2007089318A2 (en) * 2005-11-23 2007-08-09 Orexigen Therapeutics, Inc. Compositions and methods for reducing food cravings
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
DK2089005T3 (da) 2006-11-09 2010-07-19 Orexigen Therapeutics Inc Lagdelte farmaceutiske formuleringer omfattende et hurtigt opløsende mellemlag
KR20170077291A (ko) 2006-11-09 2017-07-05 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
EP2214672B1 (en) 2007-10-18 2012-10-17 Aiko Biotechnology Combination analgesic employing opioid and neutral antagonist
US8748448B2 (en) 2007-10-18 2014-06-10 Aiko Biotechnology Combination analgesic employing opioid agonist and neutral antagonist
KR101717145B1 (ko) 2008-05-20 2017-03-16 노이로제스엑스, 인코포레이티드 간보호제 아세트아미노펜 공통 프로드러그
WO2009158114A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
MX344303B (es) 2010-01-11 2016-12-13 Orexigen Therapeutics Inc Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.
SMT202500474T1 (it) 2010-12-03 2026-01-12 Nalpropion Pharmaceuticals Llc Aumento della biodisponibilità farmacologica nella terapia con naltrexone
CN110893181A (zh) 2012-06-06 2020-03-20 纳丙药业有限责任公司 治疗超重和肥胖症的方法
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
GB201704911D0 (en) 2017-03-28 2017-05-10 Ldn Pharma Ltd High dose combo I
GB201704909D0 (en) 2017-03-28 2017-05-10 Ldn Pharma Ltd Cancer therapy
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040024006A1 (en) * 1996-05-06 2004-02-05 Simon David Lew Opioid pharmaceutical compositions
EP1617832B1 (en) * 2003-04-29 2008-03-12 Orexigen Therapeutics, Inc. Compositions for affecting weight loss

Also Published As

Publication number Publication date
BRPI0613911A2 (pt) 2011-02-22
US20070117827A1 (en) 2007-05-24
MX2008001136A (es) 2008-03-13
KR20080042092A (ko) 2008-05-14
WO2007016108B1 (en) 2007-05-10
WO2007016108A1 (en) 2007-02-08
EP1907005A1 (en) 2008-04-09
CA2614539A1 (en) 2007-02-08
CN101237886A (zh) 2008-08-06
AU2006275914A1 (en) 2007-02-08
JP2009502931A (ja) 2009-01-29
RU2007147609A (ru) 2009-09-10

Similar Documents

Publication Publication Date Title
HUS2000015I1 (hu) Fungicid készítmények
IL188442A0 (en) Compositions for affecting weight loss
IL178977A0 (en) Compositions for affecting weight loss
IL191572A0 (en) Pestcidal compositions
IL186721A0 (en) Bioenhanced compositions
GB0503337D0 (en) Compositions
GB0624290D0 (en) Novel compositions
IL187664A0 (en) Herbicidal compositions
ZA200705428B (en) Stable prostaglandin-containing compositions
IL186093A0 (en) Lignan-containing compositions
IL190321A0 (en) Compositions containing saratin
GB0607085D0 (en) Novel compositions
GB0526283D0 (en) Compositions
GB0501365D0 (en) Compositions
GB0524128D0 (en) Compositions
GB0502479D0 (en) Novel compositions
GB0502475D0 (en) Novel compositions
ZA200709913B (en) Bioenhanced compositions
GB0525321D0 (en) Novel compositions
GB0526282D0 (en) Compositions
GB0524803D0 (en) Novel compositions
GB0917779D0 (en) Novel compositions
GB0501364D0 (en) Compositions
GB0506065D0 (en) Compositions
GB0505758D0 (en) Novel compositions